Precipio Commences Validation Study of Proprietary IV-Cell Cytogenetics Media at University of Pennsylvania
January 22, 2018 08:27 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO), today announced it is collaborating with the cytogenetics laboratory at the University of...